Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (21)

2023

  1. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

2022

  1. Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance

    Neurologia, Vol. 37, Núm. 2, pp. 136-150

2021

  1. Blood biomarker panels for the early prediction of stroke-associated complications

    Journal of the American Heart Association, Vol. 10, Núm. 5, pp. 1-8

  2. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

2020

  1. Blood biomarkers predictive of epilepsy after an acute stroke event

    Epilepsia, Vol. 61, Núm. 10, pp. 2244-2253

  2. Correlation of blood biomarkers with early-onset seizures after an acute stroke event

    Epilepsy and Behavior, Vol. 104

  3. Corrigendum to “Correlation of blood biomarkers with early-onset seizures after an acute stroke event” [Epilepsy Behav 104(Pt B) (2020 Mar)] (Epilepsy & Behavior (2020) 104(PB), (S1525505019305219), (10.1016/j.yebeh.2019.106549))

    Epilepsy and Behavior

  4. Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey

    Neurologia, Vol. 35, Núm. 4, pp. 252-257

2019

  1. PATJ Low Frequency Variants Are Associated with Worse Ischemic Stroke Functional Outcome: A Genome-Wide Meta-Analysis

    Circulation Research, Vol. 124, Núm. 1, pp. 114-120

  2. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study

    European Journal of Neurology, Vol. 26, Núm. 2, pp. 230-237

2018

  1. Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study

    Revista Clinica Espanola, Vol. 218, Núm. 7, pp. 327-335

2017

  1. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study

    Stroke, Vol. 48, Núm. 9, pp. 2419-2425

  2. Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain

    Revista de Neurologia, Vol. 65, Núm. 8, pp. 361-367

  3. Frequency and outcome of total anterior circulation strokes without intracranial large-vessel occlusion

    European Journal of Neurology, Vol. 24, Núm. 1, pp. 11-17

  4. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke

    Stroke, Vol. 48, Núm. 5, pp. 1147-1153

  5. Geographic dissemination of endovascular stroke thrombectomy in Catalonia within the 2011–2015 period

    European Stroke Journal, Vol. 2, Núm. 2, pp. 163-170

2016

  1. Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia

    Stroke, Vol. 47, Núm. 5, pp. 1381-1384

  2. Aplicabilidad del índice SPAN-100 en una cohorte prospectiva y contemporánea de pacientes tratados con rtPA por vía intravenosa en Cataluña

    Neurologia, Vol. 31, Núm. 9, pp. 592-598

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  2. Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study

    Cerebrovascular Diseases, Vol. 38, Núm. 5, pp. 328-336